|
US3272781A
(en)
|
1963-08-07 |
1966-09-13 |
American Potash & Chem Corp |
Boroureas of phosphinoborine polymers
|
|
FR1425700A
(fr)
|
1965-02-22 |
1966-01-24 |
Basf Ag |
Composés formant des complexes métalliques et procédé pour les préparer et les utiliser
|
|
US4208328A
(en)
|
1978-04-27 |
1980-06-17 |
General Electric Company |
Alkyl 3,5-dihydroxy-4-(2-benzothiazolyl)benzoates
|
|
US4789711A
(en)
|
1986-12-02 |
1988-12-06 |
Ciba-Geigy Corporation |
Multifunctional epoxide resins
|
|
JPH0611031Y2
(ja)
|
1988-02-27 |
1994-03-23 |
タマパック株式会社 |
ゴルフ用パッティンググリーン
|
|
DE3828535A1
(de)
|
1988-08-23 |
1990-03-08 |
Basf Ag |
Benzimidazol-2-carbonsaeureanilide, ihre verwendung als lichtschutzmittel fuer organisches material und mit diesen aniliden stabilisiertes organisches material
|
|
US5077164A
(en)
|
1989-06-21 |
1991-12-31 |
Minolta Camera Kabushiki Kaisha |
Photosensitive member containing an azo dye
|
|
DE69421982T2
(de)
|
1993-09-20 |
2000-03-30 |
Fuji Photo Film Co., Ltd. |
Positiv arbeitende Photoresistzusammensetzung
|
|
JP3461397B2
(ja)
|
1995-01-11 |
2003-10-27 |
富士写真フイルム株式会社 |
ポジ型フオトレジスト組成物
|
|
WO1998027108A2
(en)
|
1996-12-16 |
1998-06-25 |
Fujisawa Pharmaceutical Co., Ltd. |
New amide compounds and their use as nitric oxide synthase inhibitors
|
|
JPH10316853A
(ja)
|
1997-05-15 |
1998-12-02 |
Sumitomo Bakelite Co Ltd |
半導体多層配線用層間絶縁膜樹脂組成物及び該絶縁膜の製造方法
|
|
WO1999018096A1
(en)
|
1997-10-02 |
1999-04-15 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
AU2745899A
(en)
|
1998-03-05 |
1999-09-20 |
Nissan Chemical Industries Ltd. |
Anilide compounds and herbicide
|
|
JP2000128986A
(ja)
|
1998-10-28 |
2000-05-09 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール前駆体及びポリベンゾオキサゾール
|
|
JP2000128987A
(ja)
|
1998-10-28 |
2000-05-09 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール前駆体及びポリベンゾオキサゾール
|
|
JP2000128984A
(ja)
|
1998-10-28 |
2000-05-09 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール前駆体及び樹脂
|
|
US6297351B1
(en)
|
1998-12-17 |
2001-10-02 |
Sumitomo Bakelite Company Limited |
Polybenzoxazole resin and precursor thereof
|
|
PL349192A1
(en)
|
1998-12-18 |
2002-07-01 |
Axys Pharmaceuticals |
Protease inhibitors
|
|
JP2000212281A
(ja)
|
1999-01-27 |
2000-08-02 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾ―ル前駆体及びポリベンゾオキサゾ―ル樹脂
|
|
AU6000900A
(en)
|
1999-07-23 |
2001-02-13 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
|
JP2001114893A
(ja)
|
1999-10-15 |
2001-04-24 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール樹脂およびその前駆体
|
|
US6372907B1
(en)
|
1999-11-03 |
2002-04-16 |
Apptera Corporation |
Water-soluble rhodamine dye peptide conjugates
|
|
JP2001163975A
(ja)
|
1999-12-03 |
2001-06-19 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール樹脂及びその前駆体
|
|
SK13752001A3
(sk)
|
1999-12-27 |
2002-07-02 |
Japan Tobacco, Inc. |
Zlúčeniny s fúzovanými kruhmi a ich použitie ako liečiv
|
|
ES2290115T3
(es)
|
2000-02-01 |
2008-02-16 |
ABBOTT GMBH & CO. KG |
Compuestos heterociclicos y su aplicacion como inhibidores de parp.
|
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
|
US6908929B2
(en)
|
2000-03-31 |
2005-06-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Phenyl-substituted imidazopyridines
|
|
WO2001081312A2
(en)
|
2000-04-24 |
2001-11-01 |
Merck Frosst Canada & Co. |
Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
|
|
EP1294358B1
(en)
|
2000-06-28 |
2004-08-18 |
Smithkline Beecham Plc |
Wet milling process
|
|
WO2002014321A1
(en)
|
2000-08-11 |
2002-02-21 |
The Regents Of The University Of California |
Use of stat-6 inhibitors as therapeutic agents
|
|
EP1343785A2
(de)
|
2000-12-13 |
2003-09-17 |
Basf Aktiengesellschaft |
Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
|
|
ATE301653T1
(de)
|
2000-12-15 |
2005-08-15 |
Glaxo Group Ltd |
Pyrazolopyridine
|
|
SE0100567D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
|
AU2002258550B2
(en)
|
2001-03-14 |
2006-04-27 |
Eli Lilly And Company |
Retinoid X receptor modulators
|
|
WO2002078700A1
(en)
|
2001-03-30 |
2002-10-10 |
Smithkline Beecham Corporation |
Pyralopyridines, process for their preparation and use as therapteutic compounds
|
|
ATE332301T1
(de)
|
2001-04-10 |
2006-07-15 |
Smithkline Beecham Corp |
Antivirale pyrazolopyridin verbindungen
|
|
JP2002316966A
(ja)
|
2001-04-19 |
2002-10-31 |
Ueno Seiyaku Oyo Kenkyusho:Kk |
ビナフトール誘導体およびその製法
|
|
EP1385847B1
(en)
|
2001-04-27 |
2005-06-01 |
SmithKline Beecham Corporation |
Pyrazolo[1,5-a]pyridine derivatives
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
DE60220525T2
(de)
|
2001-09-07 |
2008-02-07 |
Smithkline Beecham Corp. |
Pyrazolo-pyridine für die behandlung von herpes-ansteckungen
|
|
TWI331526B
(en)
|
2001-09-21 |
2010-10-11 |
Bristol Myers Squibb Pharma Co |
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
|
|
US20030143199A1
(en)
|
2001-10-09 |
2003-07-31 |
Carson Dennis A. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
EP1434578A1
(en)
|
2001-10-09 |
2004-07-07 |
PHARMACIA & UPJOHN COMPANY |
Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands
|
|
CA2466279A1
(en)
|
2001-11-13 |
2003-05-22 |
Dana-Farber Cancer Institute, Inc. |
Agents that modulate immune cell activation and methods of use thereof
|
|
JP4024579B2
(ja)
|
2002-01-22 |
2007-12-19 |
住友ベークライト株式会社 |
プラスチック光導波路用材料及び光導波路
|
|
CA2481369C
(en)
|
2002-04-11 |
2012-07-10 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
|
|
KR20040097375A
(ko)
|
2002-04-23 |
2004-11-17 |
시오노기 앤드 컴파니, 리미티드 |
피라졸로[1, 5-에이]피리미딘 유도체 및 이를 함유한엔에이디(피)에이취 산화효소 저해제
|
|
WO2004007472A1
(ja)
|
2002-07-10 |
2004-01-22 |
Ono Pharmaceutical Co., Ltd. |
Ｃｃｒ４アンタゴニストおよびその医薬用途
|
|
WO2004006906A2
(en)
|
2002-07-15 |
2004-01-22 |
Combinatorx, Incorporated |
Methods for the treatment of neoplasms
|
|
JP2004059761A
(ja)
|
2002-07-30 |
2004-02-26 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール樹脂、その前駆体及びこれらを用いた光導波路材料並びに光導波路
|
|
CA2496633A1
(en)
|
2002-08-30 |
2004-04-29 |
Bf Research Institute, Inc. |
Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
|
|
JP2004091369A
(ja)
|
2002-08-30 |
2004-03-25 |
Sumitomo Pharmaceut Co Ltd |
新規ビフェニル化合物
|
|
JP2006504728A
(ja)
|
2002-10-03 |
2006-02-09 |
スミスクライン ビーチャム コーポレーション |
ピラソロピリジン誘導体系治療用化合物
|
|
JP2006504755A
(ja)
|
2002-10-15 |
2006-02-09 |
スミスクライン ビーチャム コーポレーション |
Ｇｓｋ−３阻害薬としてのピリダジン化合物
|
|
CN101899114A
(zh)
|
2002-12-23 |
2010-12-01 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
KR100624406B1
(ko)
|
2002-12-30 |
2006-09-18 |
삼성에스디아이 주식회사 |
비페닐 유도체 및 이를 채용한 유기 전계 발광 소자
|
|
US7320989B2
(en)
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
US7078419B2
(en)
|
2003-03-10 |
2006-07-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
|
AR043633A1
(es)
|
2003-03-20 |
2005-08-03 |
Schering Corp |
Ligandos de receptores de canabinoides
|
|
JP4595288B2
(ja)
|
2003-03-25 |
2010-12-08 |
住友ベークライト株式会社 |
ポリベンゾオキサゾール樹脂、その前駆体及びこれらを用いた光導波路材料並びに光導波路
|
|
DE602004020332D1
(de)
|
2003-04-11 |
2009-05-14 |
Glenmark Pharmaceuticals Sa |
Neue heterozyklische verbindungen, die sich für die behandlung von entzündlichen und allergischen erkrankungen eignen: verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
|
|
AU2004251146A1
(en)
|
2003-05-19 |
2005-01-06 |
Irm, Llc |
Immunosuppressant compounds and compositions
|
|
JP2005002330A
(ja)
|
2003-05-19 |
2005-01-06 |
Sumitomo Electric Ind Ltd |
光学樹脂材料、光学素子、光モジュール、フッ素化ポリマー前駆体及びフッ素化ポリマー
|
|
WO2005014599A1
(en)
|
2003-06-04 |
2005-02-17 |
Cellular Genomics, Inc. |
Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds
|
|
US20060183746A1
(en)
|
2003-06-04 |
2006-08-17 |
Currie Kevin S |
Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
|
|
US20070010573A1
(en)
|
2003-06-23 |
2007-01-11 |
Xianqi Kong |
Methods and compositions for treating amyloid-related diseases
|
|
US7393848B2
(en)
|
2003-06-30 |
2008-07-01 |
Cgi Pharmaceuticals, Inc. |
Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
|
|
CA2531856C
(en)
|
2003-07-11 |
2013-07-30 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Benzimidazole carboxamides as raf kinase inhibitors
|
|
EP1644335A4
(en)
|
2003-07-11 |
2008-06-04 |
Bristol Myers Squibb Co |
TETRAHYDROQUINOLINE DERIVATIVES COMPRISING MODULATORS OF CANNABINOID RECEPTORS
|
|
WO2005012221A1
(ja)
|
2003-08-04 |
2005-02-10 |
Ono Pharmaceutical Co., Ltd. |
ジフェニルエーテル化合物、その製造方法および用途
|
|
WO2005014543A1
(ja)
|
2003-08-06 |
2005-02-17 |
Japan Tobacco Inc. |
縮合環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
WO2005023761A2
(en)
|
2003-09-11 |
2005-03-17 |
Kemia, Inc. |
Cytokine inhibitors
|
|
EP1673343A4
(en)
|
2003-10-08 |
2008-09-10 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
|
|
US20070099938A1
(en)
|
2003-10-24 |
2007-05-03 |
Ono Pharmaceutical Co., Ltd. |
Antistress drug and medical use thereof
|
|
US20050288295A1
(en)
|
2003-11-11 |
2005-12-29 |
Currie Kevin S |
Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
|
|
EP1699763A1
(de)
|
2003-12-23 |
2006-09-13 |
Basf Aktiengesellschaft |
3-trifluormethylpicolins ureanilide und ihre verwendung als fungizide
|
|
CN1933838A
(zh)
|
2004-02-12 |
2007-03-21 |
默克公司 |
作为代谢型谷氨酸受体－5调节剂的联吡啶酰胺
|
|
EP1717238A4
(en)
|
2004-02-16 |
2008-03-05 |
Daiichi Seiyaku Co |
FUNGICIDES HETEROCYCLIC COMPOUNDS
|
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
|
JP2005248082A
(ja)
|
2004-03-05 |
2005-09-15 |
Sumitomo Electric Ind Ltd |
ポリベンゾオキサゾール樹脂前駆体の製造方法およびポリベンゾオキサゾール樹脂の製造方法
|
|
AU2005221140A1
(en)
|
2004-03-08 |
2005-09-22 |
Amgen Inc. |
Therapeutic modulation of PPAR (gamma) activity
|
|
EP1745045A4
(en)
|
2004-03-08 |
2009-07-22 |
Univ North Carolina |
NEW DIKATIONIC IMIDAZO [1,2-A] PYRIDINES AND 5,6,7,8-TETRAHYDROIMIDAZO [1,2-A] PYRIDINES AS AGENTS AGAINST PROTOZOES
|
|
CA2561791A1
(en)
|
2004-03-31 |
2005-10-20 |
Janssen Pharmaceutica, N.V. |
Non-imidazole heterocyclic compounds
|
|
JP2005290301A
(ja)
|
2004-04-02 |
2005-10-20 |
Sumitomo Electric Ind Ltd |
ポリベンゾオキサゾール樹脂前駆体の製造方法およびポリベンゾオキサゾール樹脂の製造方法
|
|
EP1735059A2
(en)
|
2004-04-06 |
2006-12-27 |
The Procter and Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
US7820704B2
(en)
|
2004-04-20 |
2010-10-26 |
Transtech Pharma, Inc. |
Substituted heteroaryl derivatives, compositions, and methods of use
|
|
DE102004021716A1
(de)
|
2004-04-30 |
2005-12-01 |
Grünenthal GmbH |
Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
|
|
WO2005108387A2
(en)
|
2004-05-03 |
2005-11-17 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
|
TW200626142A
(en)
|
2004-09-21 |
2006-08-01 |
Glaxo Group Ltd |
Chemical compounds
|
|
BRPI0515596A
(pt)
|
2004-09-23 |
2008-07-29 |
Wyeth Corp |
composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero
|
|
EP1812439B2
(en)
|
2004-10-15 |
2017-12-06 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
WO2006053121A2
(en)
|
2004-11-10 |
2006-05-18 |
Cgi Pharmaceuticals, Inc. |
Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
|
|
DE102004054665A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte bi- und tricyclische Pyrazol-Derivate Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
WO2006094235A1
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
|
CA2601628C
(en)
|
2005-03-10 |
2014-05-13 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
JP2006290883A
(ja)
|
2005-03-17 |
2006-10-26 |
Nippon Nohyaku Co Ltd |
置換ヘテロ環カルボン酸アニリド誘導体、その中間体及び農園芸用薬剤並びにその使用方法
|
|
US7906522B2
(en)
|
2005-04-28 |
2011-03-15 |
Kyowa Hakko Kirin Co., Ltd |
2-aminoquinazoline derivatives
|
|
CN109485727A
(zh)
|
2005-05-09 |
2019-03-19 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法
|
|
MX2007014510A
(es)
|
2005-05-20 |
2008-02-05 |
Array Biopharma Inc |
Compuestos inhibidores de raf y metodos de uso de los mismos.
|
|
KR101411165B1
(ko)
|
2005-07-01 |
2014-06-25 |
메다렉스, 엘.엘.시. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날항체
|
|
US20080220968A1
(en)
|
2005-07-05 |
2008-09-11 |
Ge Healthcare Bio-Sciences Ab |
[1, 2, 4] Triazolo [1, 5-A] Pyrimidine Derivatives as Chromatographic Adsorbent for the Selective Adsorption of Igg
|
|
WO2007034282A2
(en)
|
2005-09-19 |
2007-03-29 |
Pfizer Products Inc. |
Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
US20070078136A1
(en)
|
2005-09-22 |
2007-04-05 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
US8173642B2
(en)
|
2005-10-25 |
2012-05-08 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivatives
|
|
JP5249772B2
(ja)
|
2005-11-22 |
2013-07-31 |
メルク・シャープ・アンド・ドーム・コーポレーション |
キナーゼの阻害剤として有用な三環式化合物
|
|
WO2007067711A2
(en)
|
2005-12-08 |
2007-06-14 |
Amphora Discovery Corporation |
Certain chemical entities, compositions, and methods for modulating trpv1
|
|
WO2007069565A1
(ja)
|
2005-12-12 |
2007-06-21 |
Ono Pharmaceutical Co., Ltd. |
二環式複素環化合物
|
|
US20090281075A1
(en)
|
2006-02-17 |
2009-11-12 |
Pharmacopeia, Inc. |
Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
|
|
WO2007096764A2
(en)
|
2006-02-27 |
2007-08-30 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
|
|
JPWO2007102531A1
(ja)
|
2006-03-08 |
2009-07-23 |
武田薬品工業株式会社 |
併用薬
|
|
WO2007113226A1
(en)
|
2006-03-31 |
2007-10-11 |
Novartis Ag |
Organic compounds
|
|
EP2023919A4
(en)
|
2006-05-08 |
2010-12-22 |
Molecular Neuroimaging Llc |
COMPOUNDS AND AMYLOID PROBES FOR THERAPY AND IMAGING USES
|
|
EP2035005A4
(en)
|
2006-06-09 |
2011-07-06 |
Kemia Inc |
THERAPY BASED ON CYTOKINE INHIBITORS
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
CA2658764A1
(en)
|
2006-07-20 |
2008-01-24 |
Mehmet Kahraman |
Benzothiophene inhibitors of rho kinase
|
|
DE102006035018B4
(de)
|
2006-07-28 |
2009-07-23 |
Novaled Ag |
Oxazol-Triplett-Emitter für OLED-Anwendungen
|
|
WO2008021745A2
(en)
|
2006-08-16 |
2008-02-21 |
Itherx Pharmaceuticals, Inc. |
Hepatitis c virus entry inhibitors
|
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
|
|
US7563797B2
(en)
|
2006-08-28 |
2009-07-21 |
Forest Laboratories Holding Limited |
Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
|
|
US7838523B2
(en)
|
2006-09-11 |
2010-11-23 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
AU2007297221B2
(en)
|
2006-09-11 |
2012-11-08 |
Mylan Laboratories Limited |
Dibenzofuran derivatives as inhibitors of PDE-4 and PDE-10
|
|
AR063707A1
(es)
|
2006-09-11 |
2009-02-11 |
Cgi Pharmaceuticals Inc |
Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmacéuticas que las comprenden.
|
|
EP2068849A2
(en)
|
2006-09-11 |
2009-06-17 |
CGI Pharmaceuticals, Inc. |
Kinase inhibitors, and methods of using and identifying kinase inhibitors
|
|
AR063706A1
(es)
|
2006-09-11 |
2009-02-11 |
Cgi Pharmaceuticals Inc |
Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden.
|
|
FR2906250B1
(fr)
|
2006-09-22 |
2008-10-31 |
Sanofi Aventis Sa |
Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
|
|
CA2667644A1
(en)
|
2006-10-27 |
2008-05-15 |
Wyeth |
Tricyclic compounds as matrix metalloproteinase inhibitors
|
|
CA2669266C
(en)
|
2006-11-08 |
2014-04-29 |
Bristol-Myers Squibb Company |
Pyridinone compounds
|
|
GB0623209D0
(en)
|
2006-11-21 |
2007-01-03 |
F2G Ltd |
Antifungal agents
|
|
WO2008064318A2
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Peripheral opioid receptor active compounds
|
|
WO2008064317A1
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Lipophilic opioid receptor active compounds
|
|
JP2010513253A
(ja)
|
2006-12-14 |
2010-04-30 |
ベーリンガー インゲルハイム インテルナショナール ゲーエムベーハー |
炎症の治療に有用なベンゾオキサゾール類
|
|
EP2121692B1
(en)
|
2006-12-22 |
2013-04-10 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
|
EP1964840A1
(en)
|
2007-02-28 |
2008-09-03 |
sanofi-aventis |
Imidazo[1,2-a]pyridines and their use as pharmaceuticals
|
|
EP1964841A1
(en)
|
2007-02-28 |
2008-09-03 |
sanofi-aventis |
Imidazo[1,2-a]azine and their use as pharmaceuticals
|
|
EP2137158A4
(en)
|
2007-02-28 |
2012-04-18 |
Methylgene Inc |
LOW-MOLECULAR INHIBITORS OF PROTEINARGININE METHYLTRANSFERASES (PRMTS)
|
|
JP2008218327A
(ja)
|
2007-03-07 |
2008-09-18 |
Hitachi Ltd |
電解質、電解質膜、それを用いた膜電極接合体、燃料電池電源及び燃料電池電源システム
|
|
JP2010120852A
(ja)
|
2007-03-09 |
2010-06-03 |
Daiichi Sankyo Co Ltd |
新規なジアミド誘導体
|
|
PE20091225A1
(es)
|
2007-03-22 |
2009-09-16 |
Astrazeneca Ab |
Derivados de quinolina como antagonistas del receptor p2x7
|
|
EP2151435A4
(en)
|
2007-04-24 |
2011-09-14 |
Shionogi & Co |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
MX2009011498A
(es)
|
2007-04-24 |
2009-11-10 |
Shionogi & Co |
Derivados de aminodihidrotiazina sustituida con un grupo ciclico.
|
|
WO2008134553A1
(en)
|
2007-04-26 |
2008-11-06 |
Xenon Pharmaceuticals Inc. |
Methods of using bicyclic compounds in treating sodium channel-mediated diseases
|
|
EP2155747B1
(en)
|
2007-05-10 |
2012-10-24 |
GE Healthcare Limited |
Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
|
|
NZ600758A
(en)
|
2007-06-18 |
2013-09-27 |
Merck Sharp & Dohme |
Antibodies to human programmed death receptor pd-1
|
|
WO2009027733A1
(en)
|
2007-08-24 |
2009-03-05 |
Astrazeneca Ab |
(2-pyridin-3-ylimidazo[1,2-b]pyridazin-6-yl) urea derivatives as antibacterial agents
|
|
ATE505454T1
(de)
|
2007-09-20 |
2011-04-15 |
Amgen Inc |
1-(4-(4-benzylbenzamid)-benzyl)-azetidin-3- carboxylsäurederivate und entsprechende verbindungen als s1p-rezeptor-modulatoren zur behandlung von immunerkrankungen
|
|
CL2008002793A1
(es)
|
2007-09-20 |
2009-09-04 |
Cgi Pharmaceuticals Inc |
Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
|
|
DE102007048716A1
(de)
|
2007-10-11 |
2009-04-23 |
Merck Patent Gmbh |
Imidazo[1,2-a]pyrimidinderivate
|
|
TW200932219A
(en)
|
2007-10-24 |
2009-08-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
|
AU2008315746A1
(en)
|
2007-10-25 |
2009-04-30 |
Astrazeneca Ab |
Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
|
|
US7868001B2
(en)
|
2007-11-02 |
2011-01-11 |
Hutchison Medipharma Enterprises Limited |
Cytokine inhibitors
|
|
WO2009062059A2
(en)
|
2007-11-08 |
2009-05-14 |
Pharmacopeia, Inc. |
Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
|
|
EP2231143B1
(en)
|
2007-12-13 |
2013-07-03 |
Merck Sharp & Dohme Corp. |
5H-pyrido[4,3-b]indoles as INHIBITORS OF JANUS KINASES
|
|
RU2364597C1
(ru)
|
2007-12-14 |
2009-08-20 |
Андрей Александрович Иващенко |
ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
|
|
WO2009077197A1
(en)
|
2007-12-19 |
2009-06-25 |
Syngenta Participations Ag |
Insecticidal compounds
|
|
CA2709784A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
AU2008340182A1
(en)
|
2007-12-21 |
2009-07-02 |
The University Of Sydney |
Translocator protein ligands
|
|
US20100317850A1
(en)
|
2008-01-18 |
2010-12-16 |
Yuichi Suzuki |
Condensed aminodihydrothiazine derivative
|
|
JP5381718B2
(ja)
|
2008-01-31 |
2014-01-08 |
コニカミノルタ株式会社 |
ハロ多環芳香族化合物及びその製造方法
|
|
US20110009429A1
(en)
|
2008-02-26 |
2011-01-13 |
Paul Oakley |
Heterocyclic compounds as inhibitors of cxcr2
|
|
EP2095818A1
(en)
|
2008-02-29 |
2009-09-02 |
AEterna Zentaris GmbH |
Use of LHRH antagonists at non-castrating doses
|
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
|
FR2928924B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
|
|
FR2928921B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines, leur preparation et leur application en therapeutique
|
|
FR2928922B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
|
|
US8461163B2
(en)
|
2008-03-31 |
2013-06-11 |
Takeda Pharmaceutical Company Limited |
Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1
|
|
KR101034351B1
(ko)
|
2008-05-14 |
2011-05-16 |
한국화학연구원 |
신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 이상세포 성장 질환의 예방 및치료용 약학적 조성물
|
|
WO2009143156A2
(en)
|
2008-05-19 |
2009-11-26 |
Sepracor Inc. |
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
|
|
KR20110019385A
(ko)
|
2008-05-29 |
2011-02-25 |
서트리스 파마슈티컬즈, 인코포레이티드 |
시르투인 조절제로서의 이미다조피리딘 및 관련 유사체
|
|
US8163743B2
(en)
|
2008-06-05 |
2012-04-24 |
GlaxoGroupLimited |
4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
|
|
EP2323665B1
(en)
|
2008-07-24 |
2013-06-19 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
US9540322B2
(en)
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
JP2011231017A
(ja)
|
2008-09-09 |
2011-11-17 |
Nissan Chem Ind Ltd |
光学活性エポキシ化合物及び光学活性スルホキシド化合物の製造方法、並びに該方法に用いる配位子、錯体及び該錯体の製造方法
|
|
ES2592216T3
(es)
|
2008-09-26 |
2016-11-28 |
Dana-Farber Cancer Institute, Inc. |
Anticuerpos anti-PD-1, PD-L1 y PD-L2 humanos y sus usos
|
|
WO2010056875A1
(en)
|
2008-11-12 |
2010-05-20 |
Cgi Pharmaceuticals, Inc. |
Pyridazinones and their use as btk inhibitors
|
|
ES2403633T3
(es)
|
2008-12-04 |
2013-05-20 |
Proximagen Limited |
Compuestos de imidazopiridina
|
|
WO2010077634A1
(en)
|
2008-12-09 |
2010-07-08 |
Genentech, Inc. |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
CN102325753B
(zh)
|
2008-12-19 |
2014-09-10 |
百时美施贵宝公司 |
用作激酶抑制剂的咔唑甲酰胺化合物
|
|
JP5557849B2
(ja)
|
2008-12-19 |
2014-07-23 |
ブリストル−マイヤーズ スクイブ カンパニー |
カルバゾールおよびカルボリンキナーゼ阻害剤
|
|
TW201035100A
(en)
|
2008-12-19 |
2010-10-01 |
Cephalon Inc |
Pyrrolotriazines as ALK and JAK2 inhibitors
|
|
JP5624275B2
(ja)
|
2008-12-22 |
2014-11-12 |
ユー・ディー・シー アイルランド リミテッド |
有機電界発光素子
|
|
MX2011006332A
(es)
|
2008-12-23 |
2011-06-27 |
Abbott Lab |
Compuestos antivirales.
|
|
WO2010074284A1
(ja)
|
2008-12-26 |
2010-07-01 |
味の素株式会社 |
ピラゾロピリミジン化合物
|
|
US8741295B2
(en)
|
2009-02-09 |
2014-06-03 |
Universite De La Mediterranee |
PD-1 antibodies and PD-L1 antibodies and uses thereof
|
|
JP2010202530A
(ja)
|
2009-02-27 |
2010-09-16 |
Tokyo Institute Of Technology |
含ヘテロ芳香族化合物および光学材料
|
|
WO2010104307A2
(ko)
|
2009-03-07 |
2010-09-16 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 ｇｓｋ３의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
|
NZ595819A
(en)
|
2009-04-02 |
2013-02-22 |
Merck Serono Sa |
DIHYDROOROTATE DEHYDROGENASE INHIBITORS; benzimidazole-4-carboxylic acid
|
|
CN102428087B
(zh)
|
2009-04-16 |
2015-06-17 |
卡洛斯三世国家癌症研究中心基金会 |
用作激酶抑制剂的咪唑并吡嗪类化合物
|
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
|
MX336687B
(es)
|
2009-06-30 |
2016-01-28 |
Siga Technologies Inc |
Tratamiento y prevencion de infecciones del virus del dengue.
|
|
US8993604B2
(en)
|
2009-06-30 |
2015-03-31 |
Siga Technologies, Inc. |
Treatment and prevention of dengue virus infections
|
|
TWI625121B
(zh)
|
2009-07-13 |
2018-06-01 |
基利科學股份有限公司 |
調節細胞凋亡信號之激酶的抑制劑
|
|
JP2011057661A
(ja)
|
2009-08-14 |
2011-03-24 |
Bayer Cropscience Ag |
殺虫性カルボキサミド類
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
US9095596B2
(en)
|
2009-10-15 |
2015-08-04 |
Southern Research Institute |
Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
|
|
AU2010306646B2
(en)
|
2009-10-16 |
2016-09-01 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
|
US20130017199A1
(en)
|
2009-11-24 |
2013-01-17 |
AMPLIMMUNE ,Inc. a corporation |
Simultaneous inhibition of pd-l1/pd-l2
|
|
WO2011078221A1
(ja)
|
2009-12-24 |
2011-06-30 |
味の素株式会社 |
イミダゾピリダジン化合物
|
|
US20130022629A1
(en)
|
2010-01-04 |
2013-01-24 |
Sharpe Arlene H |
Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof
|
|
WO2011097607A1
(en)
|
2010-02-08 |
2011-08-11 |
Southern Research Institute |
Anti-viral treatment and assay to screen for anti-viral agent
|
|
AR080433A1
(es)
|
2010-03-02 |
2012-04-11 |
Merck Sharp & Dohme |
Derivados de benzofurancarboxamidas utiles para tratar o prevenir infecciones por vhc y composiciones farmaceuticas que los contienen.
|
|
EP2542076B1
(en)
|
2010-03-04 |
2021-01-13 |
Merck Sharp & Dohme Corp. |
Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
|
|
AU2011229423B2
(en)
|
2010-03-18 |
2015-12-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Anti-infective compounds
|
|
US8410117B2
(en)
|
2010-03-26 |
2013-04-02 |
Hoffmann-La Roche Inc. |
Imidazopyrimidine derivatives
|
|
WO2011159857A1
(en)
|
2010-06-16 |
2011-12-22 |
Bristol-Myers Squibb Company |
Carboline carboxamide compounds useful as kinase inhibitors
|
|
US9163087B2
(en)
|
2010-06-18 |
2015-10-20 |
The Brigham And Women's Hospital, Inc. |
Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions
|
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
|
CN102295642B
(zh)
|
2010-06-25 |
2016-04-06 |
中国人民解放军军事医学科学院毒物药物研究所 |
2-芳基咪唑并[1,2-a]吡啶-3-乙酰胺衍生物、其制备方法及用途
|
|
EP2402345A1
(en)
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazole fused bicyclic compounds
|
|
CN101891895B
(zh)
|
2010-07-28 |
2011-11-30 |
南京航空航天大学 |
基于桥联双水杨醛结构的苯并噻唑类金属配位聚合物及其制法及应用
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
US8633200B2
(en)
|
2010-09-08 |
2014-01-21 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
CN101993415B
(zh)
|
2010-09-15 |
2013-08-14 |
北京韩美药品有限公司 |
作为Hedgehog通路抑制剂的化合物以及包含该化合物的药物组合物及其应用
|
|
EP2624837A4
(en)
|
2010-10-04 |
2014-03-26 |
Inst Hepatitis & Virus Res |
NEW HEMMER OF THE SECRETION OF HEPATITIS B VIRUS ANTIGENES
|
|
WO2012052745A1
(en)
|
2010-10-21 |
2012-04-26 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Combinations of pi3k inhibitors with a second anti -tumor agent
|
|
EP2444084A1
(en)
|
2010-10-21 |
2012-04-25 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Use of PI3K inibitors for the treatment of obesity
|
|
WO2012068406A2
(en)
|
2010-11-18 |
2012-05-24 |
Ligand Pharmaceuticals Incorporated |
Use of hematopoietic growth factor mimetics
|
|
CN103261188A
(zh)
|
2010-12-17 |
2013-08-21 |
先正达参股股份有限公司 |
杀虫化合物
|
|
TWI617559B
(zh)
|
2010-12-22 |
2018-03-11 |
江蘇恆瑞醫藥股份有限公司 |
２－芳基咪唑并［１，２－ｂ］嗒．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡衍生物
|
|
WO2012093101A1
(en)
|
2011-01-04 |
2012-07-12 |
Novartis Ag |
Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
|
|
WO2012100342A1
(en)
|
2011-01-27 |
2012-08-02 |
Université de Montréal |
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
|
|
WO2012125886A1
(en)
|
2011-03-17 |
2012-09-20 |
Bristol-Myers Squibb Company |
Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
AU2012243329B2
(en)
|
2011-04-13 |
2015-09-17 |
Merck Sharp & Dohme Corp. |
5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use
|
|
CN102796103A
(zh)
|
2011-05-23 |
2012-11-28 |
南京英派药业有限公司 |
6-（芳基甲酰）咪唑并[1,2-a]嘧啶和6-（芳基甲酰）[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用
|
|
DK2713722T3
(en)
|
2011-05-31 |
2017-07-03 |
Celgene Int Ii Sarl |
Newly known GLP-1 receptor stabilizers and modulators
|
|
GB201109763D0
(en)
|
2011-06-10 |
2011-07-27 |
Ucl Business Plc |
Compounds
|
|
WO2012175991A1
(en)
|
2011-06-24 |
2012-12-27 |
Pharminox Limited |
Fused pentacyclic anti - proliferative compounds
|
|
CN103732596B
(zh)
|
2011-07-08 |
2016-06-01 |
诺华股份有限公司 |
吡咯并嘧啶衍生物
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
WO2013033901A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2013040528A1
(en)
|
2011-09-16 |
2013-03-21 |
Microbiotix, Inc. |
Antimicrobial compounds
|
|
WO2013043521A1
(en)
|
2011-09-22 |
2013-03-28 |
Merck Sharp & Dohme Corp. |
Pyrazolopyridyl compounds as aldosterone synthase inhibitors
|
|
JP6040677B2
(ja)
|
2011-09-29 |
2016-12-07 |
東洋インキＳｃホールディングス株式会社 |
太陽電池封止材用樹脂組成物
|
|
WO2013054291A1
(en)
|
2011-10-13 |
2013-04-18 |
Novartis Ag |
Novel oxazine derivatives and their use in the treatment of disease
|
|
AU2012325916A1
(en)
|
2011-10-20 |
2014-05-01 |
Glaxosmithkline Llc |
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
|
|
US20150126530A1
(en)
|
2011-10-21 |
2015-05-07 |
Torrent Pharmaceuticals Limited |
Novel Substituted Imidazopyrimidines as Gpbar1 Receptor Modulators
|
|
WO2013120040A1
(en)
|
2012-02-10 |
2013-08-15 |
Children's Medical Center Corporation |
Targeted pathway inhibition to improve muscle structure, function and activity in muscular dystrophy
|
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
EP2824099A4
(en)
|
2012-03-09 |
2015-11-11 |
Carna Biosciences Inc |
NOVEL TRIAZINE DERIVATIVE
|
|
PT2825042T
(pt)
|
2012-03-15 |
2018-11-16 |
Celgene Car Llc |
Sais de um inibidor de cinases do recetor do fator de crescimento epidérmico
|
|
WO2013157021A1
(en)
|
2012-04-20 |
2013-10-24 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
|
EP3070081B1
(en)
|
2012-04-20 |
2018-02-28 |
Gilead Sciences, Inc. |
Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
|
|
US20150105433A1
(en)
|
2012-04-27 |
2015-04-16 |
The Uab Research Foundation |
TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
|
|
JP6168055B2
(ja)
|
2012-06-18 |
2017-07-26 |
住友化学株式会社 |
縮合複素環化合物
|
|
EP2871179A4
(en)
|
2012-07-03 |
2016-03-16 |
Ono Pharmaceutical Co |
CONNECTION WITH AGONISTIC EFFECT ON THE SOMATOSTATIN RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
|
|
GB201212513D0
(en)
|
2012-07-13 |
2012-08-29 |
Ucb Pharma Sa |
Therapeutic agents
|
|
BR112015000675B1
(pt)
|
2012-07-13 |
2022-07-12 |
UCB Biopharma SRL |
Derivados de imidazopiridina como moduladores da atividade de tnf
|
|
JP2015178457A
(ja)
|
2012-07-25 |
2015-10-08 |
杏林製薬株式会社 |
ピラゾロピリジン誘導体、またはその薬理学的に許容される塩
|
|
EP2892899B1
(en)
|
2012-09-06 |
2018-03-21 |
Bristol-Myers Squibb Company |
Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
|
SI2900657T1
(sl)
|
2012-09-26 |
2020-07-31 |
F. Hoffmann-La Roche Ag |
Ciklični eter pirazol-4-il-heterociklil-karboksamidne spojine in načini uporabe
|
|
WO2014061693A1
(ja)
|
2012-10-17 |
2014-04-24 |
塩野義製薬株式会社 |
新規非芳香族炭素環又は非芳香族複素環誘導体
|
|
EP2922548A4
(en)
|
2012-11-21 |
2016-06-01 |
Stategics Inc |
SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROPOLATION, DIFFERENTIATION AND OVER LIVING
|
|
JP6037804B2
(ja)
|
2012-12-03 |
2016-12-07 |
富士フイルム株式会社 |
ガス分離膜
|
|
LT2945939T
(lt)
|
2013-01-15 |
2020-07-27 |
Incyte Holdings Corporation |
Triazolkarboksamidai ir piridinkarboksamido junginiai, naudotini kaip pim kinazės inhibitoriai
|
|
US20150376172A1
(en)
|
2013-01-22 |
2015-12-31 |
Thomas Woltering |
Fluoro-[1,3]oxazines as bace1 inhibitors
|
|
CN103933036B
(zh)
|
2013-01-23 |
2017-10-13 |
中国人民解放军军事医学科学院毒物药物研究所 |
2‑芳基咪唑并[1,2‑α]吡啶‑3‑乙酰胺衍生物在制备防治PTSD的药物中的用途
|
|
US9657082B2
(en)
|
2013-01-31 |
2017-05-23 |
Thomas Jefferson University |
PD-L1 and PD-L2-based fusion proteins and uses thereof
|
|
MX2015010971A
(es)
|
2013-02-27 |
2015-10-26 |
Mochida Pharm Co Ltd |
Derivado novedoso de pirazol.
|
|
EA201591614A1
(ru)
|
2013-03-08 |
2015-12-30 |
Эмджен Инк. |
Соединения 1,3-оксазин-2-амина, конденсированные с перфторированным циклопропилом, в качестве ингибиторов бета-секретазы и способы их применения
|
|
CN104045552B
(zh)
|
2013-03-13 |
2019-06-11 |
江苏先声药业有限公司 |
作为神经保护剂的药用化合物
|
|
JP2016516399A
(ja)
|
2013-03-13 |
2016-06-09 |
オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション |
非機能性ｔｓｐｏ遺伝子を有するトランスジェニック非ヒト生物
|
|
EP2968265A4
(en)
|
2013-03-14 |
2016-12-28 |
Celtaxsys Inc |
INHIBITORS OF THE LEUKOTRIEN A4 HYDROLASE
|
|
JP6603649B2
(ja)
|
2013-03-14 |
2019-11-06 |
キュラデブ ファーマ プライベート リミテッド |
キヌレニン経路の阻害剤
|
|
CN105189503B
(zh)
|
2013-03-14 |
2017-03-22 |
百时美施贵宝公司 |
人免疫缺陷病毒复制的抑制剂
|
|
US10273243B2
(en)
|
2013-03-14 |
2019-04-30 |
The Trustees Of Columbia University In The City Of New York |
4-phenylpiperidines, their preparation and use
|
|
RU2680100C9
(ru)
|
2013-03-15 |
2019-04-18 |
Плексксикон Инк. |
Гетероциклические соединения и их применения
|
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
NZ754039A
(en)
|
2013-06-26 |
2021-06-25 |
Abbvie Inc |
Primary carboxamides as btk inhibitors
|
|
EP3016949B1
(en)
|
2013-07-02 |
2020-05-13 |
Syngenta Participations AG |
Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents
|
|
JP6503336B2
(ja)
|
2013-07-17 |
2019-04-17 |
大塚製薬株式会社 |
シアノトリアゾール化合物
|
|
KR20160034379A
(ko)
|
2013-07-25 |
2016-03-29 |
다나-파버 캔서 인스티튜트 인크. |
전사 인자의 억제제 및 그의 용도
|
|
EP2835375A1
(en)
|
2013-08-09 |
2015-02-11 |
Fundació Institut Català d'Investigació Química |
Bis-salphen compounds and carbonaceous material composites comprising them
|
|
KR101715090B1
(ko)
|
2013-08-28 |
2017-03-13 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
|
EA029901B1
(ru)
|
2013-09-04 |
2018-05-31 |
Бристол-Майерс Сквибб Компани |
Соединения для применения в качестве иммуномодуляторов
|
|
DK3363790T3
(da)
|
2013-09-06 |
2020-04-27 |
Aurigene Discovery Tech Ltd |
1,2,4-oxadiazolderivater som immunmodulatorer
|
|
CU24345B1
(es)
|
2013-09-06 |
2018-05-08 |
Aurigene Discovery Tech Ltd |
Derivados de 1,3,4-oxadiazol y 1,3,4-tiadiazol como inmunomoduladores
|
|
WO2015036927A1
(en)
|
2013-09-10 |
2015-03-19 |
Aurigene Discovery Technologies Limited |
Immunomodulating peptidomimetic derivatives
|
|
JP6336870B2
(ja)
|
2013-09-30 |
2018-06-06 |
日本ポリプロ株式会社 |
ビフェノール化合物及びそれを用いるオレフィン重合用触媒並びにオレフィン重合体の製造方法
|
|
FR3012140B1
(fr)
|
2013-10-18 |
2016-08-26 |
Arkema France |
Unite et procede pour la purification de methacrylate de methyle brut
|
|
GB201321733D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321743D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321746D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321736D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
WO2015095337A2
(en)
|
2013-12-18 |
2015-06-25 |
The Rockefeller University |
PYRAZOLO[1,5-a]PYRIMIDINECARBOXAMIDE DERIVATIVES FOR TREATING COGNITIVE IMPAIRMENT
|
|
KR20160104065A
(ko)
|
2014-01-03 |
2016-09-02 |
바이엘 애니멀 헬스 게엠베하 |
농약으로서의 신규 피라졸릴헤테로아릴아미드
|
|
JP2017512056A
(ja)
|
2014-02-10 |
2017-05-18 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
ヒト・タウに結合する抗体および該抗体を使用してヒト・タウを定量するためのアッセイ
|
|
AP2016009438A0
(en)
|
2014-02-25 |
2016-09-30 |
Achillion Pharmaceuticals Inc |
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
|
|
US9394365B1
(en)
|
2014-03-12 |
2016-07-19 |
Yeda Research And Development Co., Ltd |
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
|
|
JP6490464B2
(ja)
|
2014-03-26 |
2019-03-27 |
三井化学株式会社 |
遷移金属化合物、オレフィン重合用触媒およびオレフィン系重合体の製造方法
|
|
CA2944240A1
(en)
|
2014-04-04 |
2015-10-08 |
Iomet Pharma Ltd |
Indole derivatives as ido/tdo inhibitors
|
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
US20170244049A1
(en)
|
2014-05-14 |
2017-08-24 |
President And Fellows Of Harvard College |
Organic light-emitting diode materials
|
|
CN106065009B
(zh)
|
2014-06-28 |
2019-03-01 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的化合物及其在药物中的应用
|
|
CN104211726B
(zh)
|
2014-08-11 |
2017-06-16 |
中南民族大学 |
非茂类三齿双核钛配合物、制备方法及用途
|
|
WO2016044604A1
(en)
|
2014-09-17 |
2016-03-24 |
Epizyme, Inc. |
Carm1 inhibitors and uses thereof
|
|
WO2016041511A1
(en)
|
2014-09-19 |
2016-03-24 |
Yen-Ta Lu |
Benzo-heterocyclic compounds and their applications
|
|
UA125061C2
(uk)
|
2014-10-06 |
2022-01-05 |
Мерк Патент Ґмбг |
Сполуки гетероарилу як інгібітори ткб і їх застосування
|
|
WO2016094688A1
(en)
|
2014-12-10 |
2016-06-16 |
Massachusetts Institute Of Technology |
Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
|
|
JP6853619B2
(ja)
|
2015-01-16 |
2021-03-31 |
大塚製薬株式会社 |
シアノトリアゾール化合物の医薬用途
|
|
EP3261442B1
(en)
|
2015-01-20 |
2020-04-01 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxides bearing an amine-linked substituent as bace inhibitors, compositions, and their use
|
|
DE112016000383A5
(de)
|
2015-01-20 |
2017-10-05 |
Cynora Gmbh |
Organische Moleküle, insbesondere zur Verwendung in optoelektronischen Bauelementen
|
|
WO2016156282A1
(en)
|
2015-04-02 |
2016-10-06 |
Bayer Cropscience Aktiengesellschaft |
Novel triazole compounds for controlling phytopathogenic harmful fungi
|
|
WO2017035405A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Amino compounds for treatment of immune and inflammatory disorders
|
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
EP3365340B1
(en)
|
2015-10-19 |
2022-08-10 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
US10633370B2
(en)
|
2015-10-21 |
2020-04-28 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Phenyl indole allosteric inhibitors of p97 ATPase
|
|
US9603950B1
(en)
|
2015-10-25 |
2017-03-28 |
Institute Of Nuclear Energy Research |
Compounds of imaging agent with HDAC inhibitor for treatment of Alzheimer syndrome and method of synthesis thereof
|
|
KR101717601B1
(ko)
|
2015-11-10 |
2017-03-20 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
|
HUE060680T2
(hu)
|
2015-11-19 |
2023-04-28 |
Incyte Corp |
Heterociklusos vegyületek mint immunmodulátorok
|
|
WO2017106634A1
(en)
|
2015-12-17 |
2017-06-22 |
Incyte Corporation |
N-phenyl-pyridine-2-carboxamide derivatives and their use as pd-1/pd-l1 protein/protein interaction modulators
|
|
MX2018007527A
(es)
|
2015-12-22 |
2018-09-07 |
Syngenta Participations Ag |
Derivados de pirazol activos como pesticidas.
|
|
WO2017107052A1
(en)
|
2015-12-22 |
2017-06-29 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase stimulators
|
|
EP3394033B1
(en)
|
2015-12-22 |
2020-11-25 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
AU2016378482A1
(en)
|
2015-12-22 |
2018-07-12 |
Synthon B.V. |
Pharmaceutical composition comprising amorphous lenalidomide and an antioxidant
|
|
SG10202111399YA
(en)
|
2015-12-22 |
2021-11-29 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
|
KR101653560B1
(ko)
|
2016-02-02 |
2016-09-12 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
|
PE20190377A1
(es)
|
2016-04-22 |
2019-03-08 |
Incyte Corp |
Formulaciones de un inhibidor de lsd 1
|
|
WO2017192961A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
TW201808902A
(zh)
|
2016-05-26 |
2018-03-16 |
美商英塞特公司 |
作為免疫調節劑之雜環化合物
|
|
MD3472167T2
(ro)
|
2016-06-20 |
2023-02-28 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
|
US11091489B2
(en)
|
2016-06-20 |
2021-08-17 |
Novartis Ag |
Crystalline forms of a triazolopyrimidine compound
|
|
WO2017222940A1
(en)
|
2016-06-20 |
2017-12-28 |
Eli Lilly And Company |
Pegylated porcine interferon and methods of use thereof
|
|
CN109562106B
(zh)
|
2016-06-21 |
2023-03-21 |
X4 制药有限公司 |
Cxcr4抑制剂及其用途
|
|
WO2018013789A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018026971A1
(en)
*
|
2016-08-03 |
2018-02-08 |
Arising International, Llc |
Symmetric or semi-symmetric compounds useful as immunomodulators
|
|
US20180057486A1
(en)
|
2016-08-29 |
2018-03-01 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CA3034891A1
(en)
|
2016-08-30 |
2018-03-08 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds and methods of treatment
|
|
TWI795381B
(zh)
|
2016-12-21 |
2023-03-11 |
比利時商健生藥品公司 |
作為ｍａｌｔ１抑制劑之吡唑衍生物
|
|
US10858364B2
(en)
|
2016-12-21 |
2020-12-08 |
Acerta Pharma B.V. |
Imidazopyrazine inhibitors of Bruton's tyrosine kinase
|
|
EP3558973B1
(en)
|
2016-12-22 |
2021-09-15 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
EP3558989B1
(en)
|
2016-12-22 |
2021-04-14 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
|
PE20200005A1
(es)
*
|
2016-12-22 |
2020-01-06 |
Incyte Corp |
Derivados de tetrahidro imidazo[4,5-c]piridina como inductores de internalizacion pd-l1
|
|
ES2970715T3
(es)
|
2016-12-22 |
2024-05-30 |
Prec Pharmaceuticals Inc |
Composiciones y métodos para inhibir la actividad de la arginasa
|
|
EP3558963B1
(en)
|
2016-12-22 |
2022-03-23 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
MA47123A
(fr)
|
2016-12-22 |
2021-03-17 |
Incyte Corp |
Dérivés de benzooxazole en tant qu'mmunomodulateurs
|
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
|
IL272258B
(en)
|
2017-07-28 |
2022-08-01 |
Chemocentryx Inc |
Immunomodulator compounds
|
|
EP3664793B1
(en)
|
2017-08-08 |
2022-06-29 |
ChemoCentryx, Inc. |
Macrocyclic immunomodulators
|
|
CN109400522B
(zh)
|
2017-08-18 |
2023-04-28 |
上海轶诺药业有限公司 |
一种具有pd-l1抑制活性的化合物、其制备方法及用途
|
|
JP7062792B2
(ja)
|
2018-02-13 |
2022-05-06 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｐｄ－１／ｐｄ－ｌ１阻害剤
|
|
PL4212529T3
(pl)
|
2018-03-30 |
2025-07-07 |
Incyte Corporation |
Związki heterocykliczne jako immunomodulatory
|
|
JP2021520342A
(ja)
|
2018-04-03 |
2021-08-19 |
ベータ ファーマシューティカルズ カンパニー リミテッド |
免疫調節物質、組成物及びそれらの方法
|
|
EP3781556B1
(en)
|
2018-04-19 |
2025-06-18 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
HRP20230306T1
(hr)
*
|
2018-05-11 |
2023-05-12 |
Incyte Corporation |
Derivati tetrahidro-imidazo[4,5-c]piridina kao pd-l1 imunomodulatori
|
|
EA202190516A1
(ru)
|
2018-08-15 |
2021-07-02 |
Муншайн Солюшнз Ас |
Способ и устройство подачи жидкости в хвостовую трубу обсадной колонны
|
|
KR102635333B1
(ko)
|
2018-10-24 |
2024-02-15 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
SG11202105850YA
(en)
|
2018-11-02 |
2021-07-29 |
Shanghai Maxinovel Pharmaceuticals Co Ltd |
Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof
|
|
US11596692B1
(en)
|
2018-11-21 |
2023-03-07 |
Incyte Corporation |
PD-L1/STING conjugates and methods of use
|
|
CN113365995B
(zh)
|
2019-01-31 |
2025-03-04 |
贝达药业股份有限公司 |
免疫调节剂，组合物及其方法
|
|
GB201911210D0
(en)
|
2019-08-06 |
2019-09-18 |
Amlo Biosciences Ltd |
Clinical management of oropharyngeal squamous cell carcinoma
|
|
WO2021030162A1
(en)
|
2019-08-09 |
2021-02-18 |
Incyte Corporation |
Salts of a pd-1/pd-l1 inhibitor
|
|
JP7732977B2
(ja)
|
2019-09-20 |
2025-09-02 |
トランスジーン |
Ｈｐｖポリペプチドおよびｉｌ－２をコードするポックスウイルスと抗ｐｄ－ｌ１抗体の組合せ
|
|
IL291471B2
(en)
|
2019-09-30 |
2025-04-01 |
Incyte Corp |
Pyrimido[3,2–D]pyrimidine compounds as immunomodulators
|
|
CR20220237A
(es)
|
2019-11-11 |
2022-08-05 |
Incyte Corp |
Sales y formas cristalinas de un inhibidor de pd-1/pd-l1
|
|
US20230181605A1
(en)
|
2020-05-04 |
2023-06-15 |
Beyondspring Pharmaceuticals, Inc. |
Triple combination therapy for enhancing cancer cell killing in cancers with low immunogenicity
|
|
AR124001A1
(es)
|
2020-11-06 |
2023-02-01 |
Incyte Corp |
Proceso para fabricar un inhibidor pd-1 / pd-l1 y sales y formas cristalinas del mismo
|
|
US11780836B2
(en)
|
2020-11-06 |
2023-10-10 |
Incyte Corporation |
Process of preparing a PD-1/PD-L1 inhibitor
|
|
WO2022099075A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Crystalline form of a pd-1/pd-l1 inhibitor
|
|
WO2022133176A1
(en)
|
2020-12-18 |
2022-06-23 |
Incyte Corporation |
Oral formulation for a pd-l1 inhibitor
|
|
US20230149409A1
(en)
|
2021-09-24 |
2023-05-18 |
Incyte Corporation |
Treatment of human papillomavirus-associated cancers by pd-l1 inhibitors
|